×
ADVERTISEMENT

abiraterone

New Standard of Care for Metastatic Castration-Sensitive Prostate Cancer?

Adding niraparib (Zejula, GSK) to abiraterone acetate (Akeega, Janssen) plus prednisone (AAP) can help improve ...

JULY 23, 2025

Akeega Plus Prednisone Approved for BRCA-mutated mCRPC

The FDA approved the fixed dose combination of niraparib and abiraterone acetate (Akeega, Janssen Biotech, Inc.), ...

AUGUST 14, 2023

Lynparza With Abiraterone and Prednisone (or Prednisolone) Approved for BRCA-mutated mCRPC

The FDA approved olaparib (Lynparza, AstraZeneca) with abiraterone and prednisone (or prednisolone) for adult ...

JUNE 2, 2023

For mCSPC, Abiraterone Plus ADT and Docetaxel Improves rPFS

In men with de novo metastatic castration-sensitive prostate cancer, the addition of abiraterone (Zytiga, Janssen) ...

SEPTEMBER 2, 2021

Abiraterone + ADT Shows Strong Benefits in Prostate Cancer Trials

Chicago—In patients with newly diagnosed advanced prostate cancer, initiating abiraterone at the same time as ...

JULY 6, 2017

Load more